IL1B and breast carcinoma: Breast cancer-associated fibroblast (CAF)-derived IL-1β in TME drives an immunosuppressive phenotype by promoting TAM’s reprogramming to an M2-like phenotype and restricting the accumulation of T cells in tumors (23).